Robeco Institutional Asset Management B.V. Biomarin Pharmaceutical Inc Transaction History
Robeco Institutional Asset Management B.V.
- $51.9 Billion
- Q4 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 86,574 shares of BMRN stock, worth $5.37 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
86,574
Previous 210,666
58.9%
Holding current value
$5.37 Million
Previous $14.8 Million
61.57%
% of portfolio
0.01%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding BMRN
# of Institutions
639Shares Held
178MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.41 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.2 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.17 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$862 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$651 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...